Sign in
ACET Stock Price, Chart, Stats & News
Adicet Bio, Inc.
Save
Adicet Bio, Inc. (ACET) does not currently pay a dividend.
84.32M
Market cap
–
Current P/E
–
Forward P/E
ACET chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -60.72% |
ROE | -82.96% |
D/E | 0.09x |
Interest coverage ratio | -3392.06x |
ACET valuation
P/E | – |
P/S | – |
P/B | 0.28x |
P/CF | -0.47x |
P/FCF | -0.64x |
P/OCF | -0.47x |
PEG | -0.04x |
EV multiple | -0.75x |
About
Adicet Bio, Inc. is a biotechnology firm dedicated to pioneering allogeneic gamma delta T cell therapies, aiming to treat cancer and various other diseases. The company’s strategy involves engineering gamma delta T cells with chimeric antigen receptors (CARs) and T cell receptor-like antibodies. This advanced modification is designed to achieve more precise targeting of tumors, enhance the body's natural and acquired immune responses against cancer, and provide sustained therapeutic benefits for patients.
Similar securities
Based on sector and market capitalization
Report issue